Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $409000.0.

  • Biodesix's Other Non Operating Income rose 935.83% to $409000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $558000.0, marking a year-over-year increase of 84400.0%. This contributed to the annual value of -$248000.0 for FY2024, which is 423333.33% down from last year.
  • Latest data reveals that Biodesix reported Other Non Operating Income of $409000.0 as of Q3 2025, which was up 935.83% from $51000.0 recorded in Q2 2025.
  • Over the past 5 years, Biodesix's Other Non Operating Income peaked at $3.1 million during Q3 2021, and registered a low of -$6.4 million during Q4 2022.
  • In the last 5 years, Biodesix's Other Non Operating Income had a median value of -$31500.0 in 2023 and averaged -$752222.2.
  • Within the past 5 years, the most significant YoY rise in Biodesix's Other Non Operating Income was 1860000.0% (2024), while the steepest drop was 3880000.0% (2024).
  • Over the past 5 years, Biodesix's Other Non Operating Income (Quarter) stood at -$97000.0 in 2021, then crashed by 6547.42% to -$6.4 million in 2022, then surged by 100.03% to $2000.0 in 2023, then soared by 18600.0% to $374000.0 in 2024, then increased by 9.36% to $409000.0 in 2025.
  • Its Other Non Operating Income was $409000.0 in Q3 2025, compared to $51000.0 in Q2 2025 and $98000.0 in Q1 2025.